American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||
| Net Income | 1,127 | 1,316 | -538 |
| Depreciation Amortization | 403 | 384 | 121 |
| Income taxes - deferred | 34 | -63 | N/A |
| Accounts receivable | -383 | -743 | -3 |
| Accounts payable and accrued liabilities | 328 | -76 | 18 |
| Other Working Capital | 457 | -679 | 15 |
| Other Operating Activity | 55 | 876 | 12 |
| Operating Cash Flow | $2,021 | $1,015 | $-376 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -530 | -160 | 0 |
| Investing Cash Flow | $-530 | $-160 | $0 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | N/A | 382 |
| Common Stock Issued | N/A | N/A | 1 |
| Financing Cash Flow | $N/A | $N/A | $383 |
| Beginning Cash Position | 1,326 | 470 | 4 |
| End Cash Position | 2,817 | 1,326 | 11 |
| Net Cash Flow | $1,491 | $855 | $7 |
| Free Cash Flow | |||
| Operating Cash Flow | 2,021 | 1,015 | -376 |
| Capital Expenditure | -530 | -160 | 0 |
| Free Cash Flow | 1,491 | 855 | -376 |